Your browser doesn't support javascript.
loading
Tumor immune microenvironment of primary prostate cancer with and without germline mutations in homologous recombination repair genes.
Trigos, Anna Sofia; Pasam, Anupama; Banks, Patricia; Wallace, Roslyn; Guo, Christina; Keam, Simon; Thorne, Heather; Mitchell, Catherine; Lade, Stephen; Clouston, David; Hakansson, Alexander; Liu, Yang; Blyth, Benjamin; Murphy, Declan; Lawrentschuk, Nathan; Bolton, Damien; Moon, Daniel; Darcy, Phil; Haupt, Ygal; Williams, Scott G; Castro, Elena; Olmos, David; Goode, David; Neeson, Paul; Sandhu, Shahneen.
Affiliation
  • Trigos AS; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Pasam A; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Banks P; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Wallace R; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Guo C; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Keam S; Institute of Cancer Research Sutton, Sutton, Surrey, UK.
  • Thorne H; Royal Marsden Hospital Sutton, Sutton, London, UK.
  • Mitchell C; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Lade S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Clouston D; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Liu Y; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Blyth B; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Murphy D; TissuPath, Melbourne, Victoria, Australia.
  • Lawrentschuk N; Veracyte Inc, South San Francisco, California, USA.
  • Bolton D; Veracyte Inc, South San Francisco, California, USA.
  • Moon D; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Darcy P; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Haupt Y; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Williams SG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Castro E; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Olmos D; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Goode D; Austin Hospital, Heidelberg, Victoria, Australia.
  • Neeson P; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sandhu S; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
J Immunother Cancer ; 10(6)2022 06.
Article de En | MEDLINE | ID: mdl-35764368
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Mutation germinale Type d'étude: Prognostic_studies Limites: Humans / Male Langue: En Journal: J Immunother Cancer Année: 2022 Type de document: Article Pays d'affiliation: Australie Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Mutation germinale Type d'étude: Prognostic_studies Limites: Humans / Male Langue: En Journal: J Immunother Cancer Année: 2022 Type de document: Article Pays d'affiliation: Australie Pays de publication: Royaume-Uni